The Week in Review: Fosun Pharma Given OK for Hong Kong IPO
April 14, 2012
Shanghai Fosun Pharma received approval for a Hong Kong IPO that will raise between $600 million and $800 million; China Cord Blood Group announced Kohlberg Kravis Roberts will invest $65 million into... Read More
from ChinaBio® Today
Lotus Pharma Runs Out of Cash
April 10, 2012
Lotus Pharmaceuticals said the costs of building a new Beijing headquarters building have brought on a cash crunch. To save money, Lotus will stop paying outside auditors, a move that will eventually... Read More
from ChinaBio® Today
Shenzhen Edan Instruments, a medical device maker, completed a ChiNext IPO, raising $146 million; Aslan Pharma of Singapore announced a $12 million Series A funding, which it will use to in-license... Read More
from ChinaBio® Today
Cash-strapped Lotus Pharma Explains CapEx Decisions
April 25, 2011
Lotus Pharmaceuticals (????????) will be as much as six months late in completing its new Beijing facility, a combination of corporate headquarters, R&D labs, manufacturing, a crucial warehouse – and... Read More
from ChinaBio® Today
Interactive Brokers (IBKR) To Raise Margin Requirements on China Reverse Merger Stocks to 100% (BORN) (CCME) (HOGS) (DEER) (more...)
April 11, 2011
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here